Clinical Trial Update: Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia

View source ↗

Summary

Clinical trial update for adjunctive fosfomycin in the treatment of Staphylococcus aureus bacteremia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• Fosfomycin (Fosfomycin)

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Staphylococcus Aureus Bacteremia | Status: ACTIVE_NOT_RECRUITING